Home
RSSSchering-Plough, the leading US drugs firm, has agreed to buy Akzo Nobel NV’s drugs unit Organon BioSciences for $14.4 billion in a bid to gain scale and diversify away from cholesterol medicine. The cash sale has marked last-minute reversal of...
Related Stories
Most Recent
Most Popular
Most Commented
15
Star It 
(0)
Brazil is proving to be the best alternative for national - and even foreign - companies to maintain their cash flows in the face of retracted global markets and of the...
made popular 7 hr. ago
I find that every body who thinks he is somebody has an opinion on budget. I consider myself to be no body still as self worth has no relation with net worth I also...
made popular 13 hr. ago
With his clean white university sweatshirt and shiny cellphone, Lee Chang-shik looks the part of a manager at a condominium development company, the job that he held...
made popular Jul 7 2009
* Vice minister sees dollar pre-eminence for years to come
* Idea of new reserve currency is ‘academic discussion’
* China appreciates U.S. govt efforts...
made popular Jul 7 2009
How they rip you off in the USA? As an MBA from a top business school in India I had been taught and accepted it as axiomatic that it was the American management...
made popular Jul 7 2009
While sending my answers to yourstory.in today, I came across a question - “Do you have any tips to share with budding entrepreneurs?”. I thought this might...
made popular Jul 1 2009
An advertising campaign for a hotel in Amsterdam has proved that honesty is the best policy. When brands are blowing their own trumpets by describing their unique and...
made popular Jun 30 2009
The world’s central bankers have warned that the British economy faces relapsing into another recession – the much-feared “double dip”...
made popular Jun 30 2009
The Financial Times reports that American television will face a $2 billion lose in advertising revenue over the next four years due to competing video mediums....
made popular Jun 30 2009
I am coming across more and more people who are just working for the sake of working - whether the work is paying them well or keeping them busy. It’s the same...
made popular Jun 30 2009
Yes. News bloopers do happen. Every year. Some are real. Some are fake ones created for attracting some free attention. If this video is fake, it is a kind of...
made popular Jun 29 2009
The Economist has succeeded to catch some curious glances through this billboard. By shooting some questions, the billboard leaves the viewer groping for answers. The...
made popular Jun 29 2009
Baci perugina, the chocolate brand in Italy, banks on love and romance to make it sweet and tempting. In its integrated campaign, the chocolate brand decided to sell...
made popular Jun 28 2009
Well-known high street furniture store Habitat has issued an apology (via its PR company, via a social media blog) for its misuse of popular hashtags on Twitter over...
made popular Jun 24 2009
The discussion around the Chris Anderson goof episode raises an interesting issue.
Is WordPress.com bad for the WordPress brand?
Think I am being to strong? Check out...
made popular Jun 24 2009
Tired of reading shocking headlines? Then, here is good news for you. Yes, good news, literally. Sears and AOL have launched GNN.com, which handles only feel good...
made popular Jun 24 2009
After the success of its first Startup event in Bangalore, Xtreme Startups team is excited to invite you to the 2nd edition of Startup Morning on 27th June, 2009 at...
made popular Jun 24 2009
If you are in the startup and technology circle, you must have definitely heard of Y Combinator’s Paul Graham. I came across this really good article about him...
made popular Jun 24 2009
Europe and the United States announced last night co-ordinated action against China for busting World Trade Organisation (WTO) rules by restricting exports of essential...
made popular Jun 24 2009
Is business a bad word? What will be your opinion while watching this commercial supporting Aung San Suu Kyi, the Nobel Peace Prize winner who has been imprisoned in...
made popular Jun 24 2009
All Stories
Most Recent
Most Popular
Most Commented
AP, New York
Schering-Plough, in the process of being acquired by competitor Merck, says drug sales fell in the first quarter but profit tripled because of a charge in last...
made popular Apr 21 2009
AP, New York
Fears over shaky credit markets are baked into Merck’s $41.1 billion agreement to buy rival drugmaker Schering-Plough.
made popular Mar 10 2009
AP, New York
Wall Street managed an advance Monday after a drugmakers Merck and Schering-Plough announced a $41 billion deal.
made popular Mar 9 2009
AP, New York
Stocks were fluctuating Monday as a $41 billion deal between drugmakers Merck and Schering-Plough did little to jolt investors out of their pessimistic mood.
made popular Mar 9 2009
AP, New York
Stocks are falling as a $41 billion deal between drugmakers Merck and Schering-Plough does little to jolt investors out of their pessimistic mood.
made popular Mar 9 2009
AP, New York
Stock futures are pointing lower after drugmakers Merck and Schering-Plough announced a $41 billion cash-and-stock deal.
made popular Mar 9 2009
AP, New York
Schering-Plough reports a swing to fourth-quarter profit on reduced charges from the Organon Biosciences NV buyout, but a stronger U.S. dollar and lagging cholesterol...
made popular Feb 3 2009
AP, New York
Schering-Plough says third-quarter profit fell 23 percent on higher costs, but the results still beat Wall Street expectations on strong sales of the arthritis drug...
made popular Oct 21 2008
AP, Washington
House Democrats are questioning whether Merck and Schering-Plough made up information about a meeting of medical experts to discuss Vytorin, after lawmakers began...
made popular Apr 11 2008
AP, New York
Shares of Merck and Schering-Plough plunged Monday to their lowest levels in years as new clinical data raised questions about their heart drugs.The companies market...
made popular Mar 31 2008
Researchers’ efforts seem to be coming to fruition as drug giant Pfizer Inc. is planning to bring anti-AIDS drug into the market. Now you may ask what is peculiar...
made popular Mar 2 2007
Lawyers have filed a class action lawsuit in the United States against five leading US Suntan lotion makers. They allege that the companies have misguided their...
made popular Apr 1 2006
Related Tags
Business Carl earns Edwards fears Kenilworth Merck NASCAR New York North America Pictorial Plough Schering stock stocks street U.S. United States wall Wall Street
Images
Kenilworth:
Claritin(R) Renews Sponsorship With Allergy Sufferer and NASCAR Star Carl Edwards.(PRNewsFoto/Schering-Plough)
